Pazopanib cancer drug

Pazopanib cancer drug

C038/7533 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.3MB

Downloadable file size: 695.4KB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Pazopanib cancer drug. Bottle containing 200mg tablets of the anti-cancer drug pazopanib, marketed under the name Votrient. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis, the production of new blood vessels. It is used to treat renal cell (kidney) carcinoma and soft tissue sarcoma.

Release details: Model release not required. Property release not required.

Keywords: 200mg, bottle, cancer, cancers, caplet, caplets, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, drugs, healthcare, kidney cancer, medical, medicine, multi-targeted, no-one, nobody, oncological, oncology, packaged, packaging, pazopanib, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, prescribed, prescription, receptor tyrosine kinase inhibitor, renal, renal cell carcinoma, selective, soft tissue sarcoma, still life, still-life, tub, votrient, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.